Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment
BMC infectious diseases, Volume 16, Issue 1, 2016, Pages 325
Delayed treatmentLung indexLung virus titerPeramivirSurvival rate
Delayed treatment with China-made Peramivir can reduce the severity of influenza disease, accelerate viral clearance and enhance the survival rate. This drug therefore shows good efficacy and is a promising candidate to control the influenza epidemic in China.
Full Text (Upload PDF)